Literature DB >> 6374071

Measurement of metabolic extraction of tracers in the lung using a multiple indicator dilution technique.

J Rahimian, E C Glass, J J Touya, S F Akber, L S Graham, L R Bennett.   

Abstract

Selective pulmonary uptake of many natural and synthetic substances has been demonstrated by physiologists and pharmacologists using isolated perfused lung preparations or invasive techniques. It is difficult, however, to relate these laboratory studies to disease processes and to the study of problems encountered in a clinical environment. Our goal was to develop a noninvasive method for studying the pulmonary uptake of tracer substances using available radiotracers, gamma cameras, and computers that would give information similar, if not identical, to that from the invasive laboratory methods, and that could be applied in a clinical setting. The multiple-indicator dilution technique, modified for external counting, is well suited for such studies of pulmonary uptake of tracer substances. In this study, Tc-99m micro sulfur colloid (Tc-99m micro SC) was used as an intravascular reference tracer, N-isopropyl-p-[123I]iodoamphetamine (I-123 IMP) as a cellular test tracer amine, and In-111 DTPA as an extracellular tracer. Calculated first-pass lung uptakes of I-123 IMP and In-111 DTPA were 0.92 +/- 0.04 and 0.17 +/- 0.04, respectively, relative to the reference tracer. Using this approach, the first-pass pulmonary extraction of a variety of radiolabeled test tracers can be measured in a clinical environment in a variety of physiologic settings.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6374071

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  15 in total

1.  Prolonged lung retention of 123I-IMP in pulmonary fibrosis.

Authors:  H Ikeda; M Itasaka; K Takahashi; A Komatani
Journal:  Ann Nucl Med       Date:  1992-08       Impact factor: 2.668

2.  New design of N-isopropyl-p-[123I]iodoamphetamine (123I-IMP) lung imaging in the patient with lung cancer.

Authors:  E Tanaka; M Mishima; K Kawakami; N Sakai; N Sugiura; T Taniguchi; M Ohi; H Itoh; K Kuno
Journal:  Ann Nucl Med       Date:  1995-11       Impact factor: 2.668

3.  The influence of age on N-isopropyl-p-[123I]iodoamphetamine accumulation in the human heart.

Authors:  M Nakajo; Y Nakabeppu; S Iwashita; S Shinohara
Journal:  Ann Nucl Med       Date:  1990-07       Impact factor: 2.668

4.  N-isopropyl-p[123I]iodoamphetamine, a new agent for lung imaging studies.

Authors:  N Van Zandwijk; A Zwijnenburg; C A Hoefnagel; H R Marcuse
Journal:  Thorax       Date:  1986-10       Impact factor: 9.139

5.  On clinical usefulness of Tl-201 scintigraphy for the management of malignant soft tissue tumors.

Authors:  S Terui; T Terauchi; H Abe; H Fukuma; Y Beppu; K Chuman; R Yokoyama
Journal:  Ann Nucl Med       Date:  1994-02       Impact factor: 2.668

6.  I-123 IMP scintigraphy in two patients with primary pulmonary malignant lymphoma.

Authors:  K Suga; K Nishigauchi; M Sadanaga; N Kume; H Uchisako; T Matsumoto; T Nakanishi
Journal:  Ann Nucl Med       Date:  1994-02       Impact factor: 2.668

7.  131I-metaiodobenzylguanidine and 125I-iodoamphetamine. Parameters of lung endothelial cell function and pulmonary vascular area.

Authors:  D O Slosman; A Donath; P O Alderson
Journal:  Eur J Nucl Med       Date:  1989

8.  N-isopropyl-p-iodoamphetamine receptors in normal and cancerous tissue of the human lung.

Authors:  E Tanaka; M Mishima; K Kawakami; N Sakai; N Sugiura; T Taniguchi; K Kuno
Journal:  Eur J Nucl Med       Date:  1993-04

9.  Lung uptake of 131I-metaiodobenzylguanidine in sheep. An in vivo measurement of pulmonary metabolic function.

Authors:  D O Slosman; D R Morel; P M Mo Costabella; A Donath
Journal:  Eur J Nucl Med       Date:  1988

10.  11C-butanol for imaging of the blood-flow distribution in tumor-bearing animals.

Authors:  W H Knapp; F Helus; F Oberdorfer; K Layer; H Sinn; H Ostertag; S Matzku
Journal:  Eur J Nucl Med       Date:  1985
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.